Apollomics Inc. (APLM) stock
APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
$17.68+0.38 (+2.20%)
Close on Nov 13, 2026Market cap $38.83MP/E –Yield –
Apollomics EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$7.57. The highest annual figure on record is -$0.21 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.57 | – |
| FY2024 | Dec 31, 2024 | -$52.80 | – |
| FY2023 | Dec 31, 2023 | -$231.99 | – |
| FY2022 | Dec 31, 2022 | -$844.95 | – |
| FY2021 | Dec 31, 2021 | -$3.37 | – |
| FY2020 | Dec 31, 2020 | -$0.21 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?